Literature DB >> 21775043

[Amyloidosis. Also a heart disease].

Pablo García-Pavía1, María Teresa Tomé-Esteban, Claudio Rapezzi.   

Abstract

The term cardiac amyloidosis refers to the involvement of the heart as a result of amyloid deposition in heart tissue either in the context of a systemic disease or as a localized form. Several proamyloid proteins can produce amyloid deposits in the heart. Each of these amyloidoses has characteristic clinical (cardiac and extracardiac) features, its own course, and a specific diagnosis and treatment. Since cardiac involvement may be the first-manifestation of amyloidosis, the cardiologist may be the first healthcare professional to see the patient and must always consider this diagnosis. In this review, we consider the amyloidosis characteristics that may present with cardiac involvement, from the cardiologist's viewpoint and in light of our experience. We review in detail when and how to establish the diagnosis and how to treat these patients' cardiac involvement and the underlying amyloid disease.
Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21775043     DOI: 10.1016/j.recesp.2011.05.003

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  9 in total

1.  Usefulness of electron microscopy in the diagnosis of wild-type transthyretin cardiac amyloidosis.

Authors:  Isamu Sunayama; Takahiro Yoshimura; Takuryu Sonoura; Yuka Nakamura; Yu Morishita; Takayuki Sekihara; Masashi Ishimi; Masashi Yamato; Yoshihiko Hoshida; Yoshinori Yasuoka
Journal:  J Cardiol Cases       Date:  2021-01-19

2.  A systemic disease un…suspected by physical examination.

Authors:  Cátia Costa; Davide Severino; Maria Luz Pitta; Margarida Leal
Journal:  BMJ Case Rep       Date:  2014-10-09

3.  Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.

Authors:  Jennifer Mancio Silva; Ricardo Fontes-Carvalho; Dília Valente; Cristiana Almeida; Antonio José Cruz; David Tente; Henrique Coelho; Marco Oliveira; Aníbal Albuquerque; Vasco Gama Ribeiro
Journal:  Am J Case Rep       Date:  2015-03-24

4.  Cardiac amyloidosis: a challenging diagnosis.

Authors:  Graziele Cristina Palancio Morais; Marjorie Moreira Arruda; José Carlos de Aguiar Bonadia; Geanete Pozzan
Journal:  Autops Case Rep       Date:  2014-03-30

5.  Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Authors:  Panagiota Kyriakou; Dimitrios Mouselimis; Anastasios Tsarouchas; Angelos Rigopoulos; Constantinos Bakogiannis; Michel Noutsias; Vasileios Vassilikos
Journal:  BMC Cardiovasc Disord       Date:  2018-12-04       Impact factor: 2.298

6.  Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.

Authors:  Mounira Kharoubi; Fréderic Roche; Mélanie Bézard; David Hupin; Sidney Silva; Silvia Oghina; Coraline Chalard; Amira Zaroui; Arnault Galat; Soulef Guendouz; Florence Canoui-Poitrine; Luc Hittinger; Emmanuel Teiger; Jean-Pascal Lefaucheur; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2020-12-22

Review 7.  Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.

Authors:  Jyothirmayi Velaga; Charlene Liew; Angeline Choo Choo Poh; Phong Teck Lee; Narayan Lath; Shoen Choon Low; Pushan Bharadwaj
Journal:  World J Nucl Med       Date:  2022-08-16

8.  Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.

Authors:  Rui Li; Zhi-gang Yang; Lin-yi Wen; Xi Liu; Hua-yan Xu; Qin Zhang; Ying-kun Guo
Journal:  J Cardiovasc Magn Reson       Date:  2016-04-06       Impact factor: 5.364

Review 9.  Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.

Authors:  Teodor M Ionescu; Wael Jalloul; Cati R Stolniceanu; Roxana Iacob; Laura P Grecu; Ana-Maria Stătescu; Irena Grierosu; Mihai Guțu; Adrian Gavrilescu; Crișu Daniela; Antoniu Petriș; Manuela Ciocoiu; Cristina Ungureanu; Cipriana Ștefănescu
Journal:  Ann Nucl Med       Date:  2021-07-17       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.